Leuko Raises $5 Million Series A To Validate And Bring To Market Its Noninvasive White Blood Cell Monitoring Technology For Cancer Patients
Amount Raised
$5 Million
Round Type
Series A
BostonBiotechnologyHealth CareArtificial IntelligenceMedicalDescription
Leuko, an MIT startup developing PointCheckTM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 million for their Series A round. The new funding, from HTH VC, Good Growth Capital, IAG Capital Partners, Nina Capital, and angel investors, will accelerate Leuko’s clinical trials to obtain regulatory approval in collaboration with leading cancer centers, including Boston Medical Center and MD Anderson in the USA, and Dexeus and Hospital 12 de Octubre in Europe. Leuko will also continue to pursue its go-to-market and partnership activities with healthcare providers, medical device distributors and pharmaceutical companies.
Quick answer
Leuko raised $5 Million in a Series A round, dated September 23, 2022. Leuko is based in Boston, Massachusetts, United States.
- How much did Leuko raise?
- Leuko raised $5 Million in a Series A round on September 23, 2022.
- What does Leuko do?
- Leuko is developing the first non-invasive white blood cell device.
- Where is Leuko based and how big is it?
- Leuko is based in Boston, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Leuko that raised within 45 days of this round, from Fundz verified event records.
- Carta Healthcare raised $20M (Series B) on November 2, 2022.
- Optellum raised $14M (Series A) on September 27, 2022.
- Incepto raised $27M (Funding Round) on September 19, 2022.
- FathomX raised an undisclosed amount (Pre-Series A) on September 1, 2022.
- Avenda Health, Inc. raised $10M (Series B) on August 25, 2022.
- Adastra raised an undisclosed amount on August 22, 2022.
Who to call at Leuko, and when
A new round usually means Leuko is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Leuko raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Leuko, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Leuko. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Leuko raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansLeuko raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.